Login to Your Account



Financings Roundup

QuatRx Files $86M IPO To Push Clinical Development

By Jennifer Boggs


Tuesday, February 7, 2006
A month after starting its first Phase III trial, QuatRx Pharmaceuticals Co. filed for its initial public offering, hoping to raise $86.25 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription